ANAVEX LIFE SCIENCES CORP. - 8-K Filing
FDA granted Anavex Life Sciences Corp.'s request for a meeting to discuss including pediatric patients in its Phase 3 trial of ANAVEX®2-73 for Rett syndrome. (Items: 8.01 Other Events)
Tickers: $AVXL
More Regulatory news
- Solana Co - 10-Q Filing
- Solana Co - 8-K Filing
- DeFi Development Corp. - 8-K Filing
- Stablecoin Development Corp - 8-K Filing
- BCP Investment Corp - 8-K Filing
- OneWater Marine Inc. - 8-K Filing
- Moleculin Biotech, Inc. - 8-K Filing
- Investcorp Credit Management BDC, Inc. - 8-K Filing
- Presurance Holdings, Inc. - 10-Q Filing
- Corteva, Inc. - 8-K Filing